Cargando…
Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
BACKGROUND: The purpose of this study was to characterize intraocular pressure (IOP) reduction throughout the day with travoprost ophthalmic solution 0.004% dosed once daily in the evening. METHODS: The results of seven published, randomized clinical trials including at least one arm in which travop...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334204/ https://www.ncbi.nlm.nih.gov/pubmed/22536047 http://dx.doi.org/10.2147/OPTH.S30690 |